Key Insights

Highlights

Success Rate

87% trial completion (above average)

Published Results

13 trials with published results (42%)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 5/100

Termination Rate

9.7%

3 terminated out of 31 trials

Success Rate

87.0%

+0.5% vs benchmark

Late-Stage Pipeline

26%

8 trials in Phase 3/4

Results Transparency

65%

13 of 20 completed with results

Key Signals

13 with results87% success

Data Visualizations

Phase Distribution

25Total
Not Applicable (12)
P 1 (1)
P 2 (4)
P 3 (5)
P 4 (3)

Trial Status

Completed20
Recruiting3
Terminated3
Not Yet Recruiting2
Unknown1
Active Not Recruiting1

Trial Success Rate

87.0%

Benchmark: 86.5%

Based on 20 completed trials

Clinical Trials (31)

Showing 20 of 20 trials
NCT07378514Not Yet Recruiting

Cobas® Lumira Collection of Venous and Capillary Blood Samples for the Research, Optimization and Calibration of New Diagnostic Devices

NCT07220213Not ApplicableRecruiting

FELLAShip to Better Health

NCT07347678Phase 1Not Yet RecruitingPrimary

Phase 1a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RN5681 in Healthy Volunteers

NCT07126587Not ApplicableRecruiting

Healthy Living Anson Study

NCT06005597Phase 3Completed

Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies

NCT06364163Not ApplicableActive Not RecruitingPrimary

Effect of Herring Oil Concentrate on LDL Cholesterol Concentration in Adults

NCT05142722Phase 3Completed

Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies

NCT07090629CompletedPrimary

The Benefits of the Measureof Epicardial Adipose Tissue During Coronary Calcium Assessment of the Refine Cardiovascular Risk Assessment at Reunion Island.

NCT05425745Phase 3Completed

Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies.

NCT06350604Not ApplicableCompleted

Project WHADE: A Partner-Based Physical Activity Program for Women

NCT04964544Phase 3CompletedPrimary

Technology-Assisted Cholesterol Trial in Consumers (TACTiC)

NCT05421078Phase 2Completed

A Dose-Finding Study in Japanese Patients to Evaluate the Effect of Obicetrapib as an Adjunct to Stable Statin Therapy.

NCT04753606Phase 2Completed

Randomized Study of Obicetrapib as an Adjunct to Statin Therapy

NCT05266586Phase 2Completed

Study to Evaluate the Effect of Obicetrapib in Combination With Ezetimibe as an Adjunct to HIS Therapy

NCT04770389Phase 2Completed

Randomized Study of Obicetrapib in Combination With Ezetimibe

NCT06227819Completed

BVA-200 vs BVA-100 Validation Study

NCT06192251RecruitingPrimary

Complete Lifestyle Medicine Intervention Program

NCT04317274Not ApplicableCompleted

Online Trial Examining Validity of the Shared Decision Making Process Survey With Video Vignettes

NCT03084822Not ApplicableCompleted

Cardiovascular Health Promotion Among African-Americans by FAITH!

NCT03528031Not ApplicableCompleted

Habitual Diet and Avocado Trial

Scroll to load more

Research Network

Activity Timeline